A reversible and selective inhibitor of AChE, Huperzine A (HupA), was shown to activate Wnt signaling via GSK-3β inhibition and stabilize the level of β-catenin and reduce amyloidosis in the AD brain [89]. This evidence concerns the gene GSK3B and Alzheimer disease.